BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 1997
View Archived Issues
Potent and selective dopamine D3 ligands from ADIR
Read More
Kyowa Hakko discovers inhibitors of IL-1beta production
Read More
ET antagonists claimed by Bristol-Myers Squibb
Read More
Roche describes endothelin antagonists
Read More
Antioxidant diester reported by Senju
Read More
Novel, irreversible HIV protease inhibitor disclosed by LG Chemical
Read More
Human PEP inhibitor isolated from microbial sources
Read More
Tokyo Tanabe developing oxytocin antagonist
Read More
Full 5-HT1A receptor antagonist described by Duphar
Read More
Synthesis and pharmacological profile of new antithrombotic pentasaccharide
Read More
Pharmacological profile of BMS-186716 characterized
Read More
Abelcet approved in Canada
Read More
Corvas to strengthen anticancer program with option to acquire Vascular Genomics
Read More
New immunoassay for DVT diagnosis
Read More
CoCensys reports on phase II trial with ganaxolone
Read More
Topical t-PA for the treatment of venous ulcers
Read More
Celtrix's SomatoKine enters phase II feasibility study for the treatment of burns
Read More
Injectable microsphere-encapsulated norethindrone is a safe and effective contraceptive
Read More
Edex cleared for erectile dysfunction in the U.S.
Read More
Nycomed and Amersham announce proposed merger
Read More
Sepracor submits first NDA for levalbuterol
Read More
Shire acquires distribution rights for Urispas from Recordati
Read More
Oncogene Science and Xenometrix alliance for drug discovery/lead optimization technologies
Read More
